KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $357.0 million.

  • Bausch Health Companies' Change in Accured Expenses changed negligibly% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $232.0 million, marking a year-over-year decrease of 46.05%. This contributed to the annual value of $357.0 million for FY2024, which is 125.95% up from last year.
  • According to the latest figures from FY2024, Bausch Health Companies' Change in Accured Expenses is $357.0 million, which was up 125.95% from $158.0 million recorded in FY2023.
  • Bausch Health Companies' Change in Accured Expenses' 5-year high stood at $357.0 million during FY2024, with a 5-year trough of -$471.0 million in FY2020.
  • Its 3-year average for Change in Accured Expenses is $146.7 million, with a median of $158.0 million in 2023.
  • Per our database at Business Quant, Bausch Health Companies' Change in Accured Expenses slumped by 216.11% in 2020 and then spiked by 310.67% in 2023.
  • Bausch Health Companies' Change in Accured Expenses (Yearly) stood at -$471.0 million in 2020, then spiked by 125.69% to $121.0 million in 2021, then tumbled by 161.98% to -$75.0 million in 2022, then spiked by 310.67% to $158.0 million in 2023, then skyrocketed by 125.95% to $357.0 million in 2024.